The Selective Class I PI3K Inhibitor CH5132799 Targets Human Cancers Harboring Oncogenic PIK3CA Mutations
Excerpt:
...colorectal cancer HCT116, harboring both PIK3CA and KRAS mutations, showed strong tumor growth inhibition by CH5132799, consistent with our in vitro observations.